multiple myeloma: A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)
| Name | CD2_MULTIPLE_MYELOMA_PLASMA_CELL |
|---|---|
| Long name | Multiple myeloma and malignant plasma cell neoplasms |
| Hospital Discharge registry | ICD-10: C90, ICD-9: 203, ICD-8: 203 |
| Cause of Death registry | ICD-10: C90, ICD-9: 203, ICD-8: 203 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
| Latin name | Myeloma multiplex et neoplasmata maligna plasmacytorum |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 598 | 270 | 328 |
| Unadjusted prevalence (%) | 0.28 | 0.22 | 0.35 |
| Mean age at first event (years) | 65.24 | 64.36 | 65.96 |
| Case fatality at 5-years (%) | 22.41 | 19.26 | 25.00 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 4.0 | 5.0 | 4.0 |
| Recurrence at 6 months (%) | 65.38 | 65.19 | 65.55 |
before Multiple myeloma and malignant plasma cell neoplasms
after Multiple myeloma and malignant plasma cell neoplasms
Loading survival analyses plot…
Loading survival analyses table…